QCI Interpret for Oncology
QCI Interpret One: Oncology variant interpretation just got more precise
891 views
Lab Directors can now confidently interpret variants with variant- and disease-specific, oncologist-reviewed content. They can accelerate turnaround time by generating reports in minutes with automated classification of variant actionability and on-demand access to comprehensive expert variant interpretation without the time consuming step of researching and writing evidence-based summaries. They get access to an “expert second opinion” for variant classification, and they can deliver professional reports directly to physicians to help inform clinical decision making.
Interested in learning more?
Click here
Speakers:
Beate Litzenburger, PhD, Global Product Director of Oncology for Clinical Decision Support Software and Interpretation Services at QIAGEN
Sheryl Krevsky Elkin, PhD, Chief Scientific Officer at N-of-One, a QIAGEN company
Related videos
QCI Interpret for Oncology
Rapid, evidence-based reporting of oncology NGS tests at scale
Competing to offer a comprehensive genomic profiling service for solid or...
QCI Interpret for Oncology
Gaining insights with transcriptomic profiling and mechanistic modeling
In this webinar, Moritz Schütte, head of next-generation sequencing data...
QCI Interpret for Oncology
Going beyond: Molecular evidence for off-label therapy use
Kathryn Bungartz, Ph.D., Associate StaffField Application Scientist, QIAGEN...
QCI Interpret for Oncology
Confidence and trust: Deliver valuable clinical insights with high-quality knowledge
Ben Turner, Director of Bioinformatics Enterprise Solutions, QIAGEN Digital...